Vetoquinol (XPAR:VETO) Asset Impairment Charge : €0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Vetoquinol Asset Impairment Charge?

Vetoquinol's Asset Impairment Charge for the six months ended in Dec. 2023 was €0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was €0.0 Mil.

Vetoquinol Asset Impairment Charge Historical Data

The historical data trend for Vetoquinol's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vetoquinol Asset Impairment Charge Chart

Vetoquinol Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Vetoquinol Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Vetoquinol Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

Vetoquinol Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Vetoquinol's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Vetoquinol (XPAR:VETO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vetoquinol SA (XPAR:VETO) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

8JM:Germany

Address

Magny-Vernois, BP 189, Lure cedex, FRA, 70204

Website

http://www.vetoquinol.com

Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.

Vetoquinol (XPAR:VETO) Headlines

No Headlines